Market revenue in 2023 | USD 1.8 million |
Market revenue in 2030 | USD 2.5 million |
Growth rate | 4.6% (CAGR from 2023 to 2030) |
Largest segment | Total laparoscopic hysterectomy (tlh) |
Fastest growing segment | Laparoscopic Supracervical Hysterectomy (LSH) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Total Laparoscopic Hysterectomy (TLH), Laparoscopic Supracervical Hysterectomy (LSH), Laparoscopically Assisted Vaginal Hysterectomy (LAVH), Sacrocolpopexy |
Key market players worldwide | Johnson & Johnson, The Cooper Companies Inc, B. Braun Medical, Karl Storz, Conmed Corp, RUDOLF Medical, LiNA, Richard Wolf, Utah Medical Products Inc, PURPLE SURGICAL MANUFACTURING LIMITED, Conkin Surgical Instruments, Laborie Medical Technologies, Bissinger, The O.R. Company, LSI Solutions |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to uterine manipulation devices market will help companies and investors design strategic landscapes.
Total laparoscopic hysterectomy (tlh) was the largest segment with a revenue share of 38.89% in 2024. Horizon Databook has segmented the Norway uterine manipulation devices market based on total laparoscopic hysterectomy (tlh), laparoscopic supracervical hysterectomy (lsh), laparoscopically assisted vaginal hysterectomy (lavh), sacrocolpopexy covering the revenue growth of each sub-segment from 2018 to 2030.
The rising incidence of cervical cancer in women aged under 30 and the growing awareness of women’s health issues in Norway are some of the factors contributing to market growth. According to WHO, International Agency for Research on Cancer fact sheet, 2022, cervix uteri cancer was among the top five most frequent cancers in Norway and accounted for 4.5% of all cancer in 2022.
Moreover, the growing number of nonprofit voluntary organizations supporting cancer care is one of the factors fueling the uterine manipulation devices market growth in Norway. For instance, the Norwegian Cancer Society (NCS), a non-profit voluntary organization, is one of the leading cancer NGOs in Norway and contributes to a focused effort in the area of research funding, cancer care, cancer prevention, information, and international collaboration.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway uterine manipulation devices market , including forecasts for subscribers. This country databook contains high-level insights into Norway uterine manipulation devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account